SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis

Arthritis Research and Therapy

Volumn 15, Issue 4, 2013, Pages

  Gómez Vaquero, Carmen ^a   Corrales, Alfonso ^b   Zacarías, Andrea ^a   Rueda Gotor, Javier ^b   Blanco, Ricardo ^b   González Juanatey, Carlos ^c   Llorca, Javier ^d,e   González Gay, Miguel A ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c Hospital Lucus Augusti   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DISEASE DURATION; ECHOGRAPHY; FEMALE; FRAMINGHAM REGISTRE GIRONI DEL COR; HUMAN; INTRAVASCULAR ULTRASOUND SYSTEM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPAIN; SYSTEMATIC CORONARY RISK EVALUATION; AGED; ALGORITHM; AREA UNDER THE CURVE; CARDIOVASCULAR DISEASES; COMPLICATION; MIDDLE AGED; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

AGED; ALGORITHMS; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPAIN;

EID: 84882351708     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4271     Document Type: Article

References (39)

1. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of CV mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-1697. 10.1002/art.24092, 19035419.
2. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005, 35:8-17. 10.1016/j.semarthrit.2005.03.004, 16084219.
3. Rodríguez-Rodríguez L, González-Juanatey C, García-Bermúdez M, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res Ther 2011, 13:R133. 10.1186/ar3444, 3239375, 21846359.
4. Dessein PH, Joffe BI, Veller MG, Stevens BA, Tobias M, Reddi K, Stanwix AE. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005, 32:435-442.
5. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "high-grade" msystemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003, 108:2957-2963. 10.1161/01.CIR.0000099844.31524.05, 14676136.
6. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to CV events and CV mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007, 57:125-132. 10.1002/art.22482, 17266100.
7. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ. Baseline levels of C-reactive protein and prediction of death from CV disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 2005, 52:2293-2299. 10.1002/art.21204, 16052597.
8. Jacobsson LT, Turesson C, Hanson RL, Pillemer S, Sievers ML, Pettitt DJ, Bennett PH, Knowler WC. Joint swelling as a predictor of death from CV disease in a population study of Pima Indians. Arthritis Rheum 2001, 44:1170-1176. 10.1002/1529-0131(200105)44:5<1170::AID-ANR200>3.0.CO;2-T, 11352251.
9. Wållberg-Jonsson S, Johansson H, Ohman ML, Rantapää-Dahlqvist S. Extent of inflammation predicts CV disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999, 26:2562-2571.
10. Marrugat J, Elosúa R, Martí H. Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005. Rev Esp Cardiol 2002, 55:337-346. 10.1016/S0300-8932(02)76611-6, 11975899.
11. Sans S, Kesteloot H, Kromhout D. The burden of CV diseases mortality in Europe. Task force of the European Society of Cardiology on CV Mortality and Morbidity Statistics in Europe. Eur Heart J 1997, 18:1231-1248. 10.1093/oxfordjournals.eurheartj.a015434, 9508543.
12. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003. 10.1016/S0195-668X(03)00114-3, 12788299, SCORE project group.
13. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of CV risk profiles. Am Heart J 2004, 148:16-26. 10.1016/j.ahj.2003.10.022, 15215787.
14. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, Solanas P, Cordón F, Ramos R, Sala J, Masiá R, Kannel WB. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003, 57:634-638. 10.1136/jech.57.8.634, 1732543, 12883073.
15. D'Agostino RB, Grundy S, Sullivan LM, Wilson P, The CHD Risk Prediction Group Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286:180-187. 10.1001/jama.286.2.180, 11448281, The CHD Risk Prediction Group.
16. Ramos R, Solanas P, Cordón F, Rohlfs I, Elosua R, Sala J, Masiá R, Faixedas MT, Marrugat J. Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions. Med Clin (Barc) 2003, 121:521-526.
17. Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, Nam BH, Ramos R, Sala J, Solanas P, Cordón F, Gené-Badia J, D'Agostino RB, VERIFICA Investigators Validity of an adaptation of the Framingham CV risk function: the VERIFICA study. J Epidemiol Community Health 2007, 61:40-47. 10.1136/jech.2005.038505, 2465597, 17183014, VERIFICA Investigators.
18. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT. EULAR evidence-based recommendations for CV risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010, 69:325-331. 10.1136/ard.2009.113696, 19773290.
19. Kerekes G, Soltész P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, Végh E, Shoenfeld Y, McInnes I, Szekanecz Z. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol 2012, 8:224-234. 10.1038/nrrheum.2012.16, 22349611.
20. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Martin J, Llorca J. Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 2008, 38:67-70. 10.1016/j.semarthrit.2008.02.001, 18395772.
21. Belcaro G, Nicolaides AN, Ramaswami G, Cesarone MR, De Sanctis M, Incandela L, Ferrari P, Geroulakos G, Barsotti A, Griffin M, Dhanjil S, Sabetai M, Bucci M, Martines G. Carotid and femoral ultrasound morphology screening and CV events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study (1)). Atherosclerosis 2001, 156:379-387. 10.1016/S0021-9150(00)00665-1, 11395035.
22. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, Volcik K, Boerwinkle E, Ballantyne CM. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010, 55:1600-1607. 10.1016/j.jacc.2009.11.075, 2862308, 20378078.
23. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187. 10.1097/HJH.0b013e3281fc975a, 17563527.
24. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, European Association for Cardiovascular Prevention & Rehabilitation, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011, 32:1769-1818. European Association for Cardiovascular Prevention & Rehabilitation, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees.
25. van Sijl AM, Peters MJ, Knol DK, de Vet HC, Gonzalez-Gay MA, Smulders YM, Dijkmans BA, Nurmohamed MT. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum 2011, 40:389-397. 10.1016/j.semarthrit.2010.06.006, 20889191.
26. Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003, 82:407-413. 10.1097/01.md.0000101572.76273.60, 14663290.
27. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA. Carotid intima-media thickness predicts the development of CV events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009, 38:366-371. 10.1016/j.semarthrit.2008.01.012, 18336869.
28. Evans MR, Escalante A, Battafarano DF, Freeman GL, O'Leary DH, del Rincón I. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum 2011, 63:1211-1220. 10.1002/art.30265, 3286362, 21305526.
29. Corrales A, González-Juanatey C, Peiró ME, Blanco R, Llorca J, González-Gay MA. Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 2013,
30. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
31. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010, 69:1580-1588. 10.1136/ard.2010.138461, 20699241.
32. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007, 23:75-80. 10.1159/000097034, 17108679.
33. Baena Díez JM, del Val Garcia JL, Héctor Salas Gaetgens L, Sánchez Pérez R, Altes Vaques E, Deixens Martínez B, Amatller Corominas M, Katia Núñez Casillas D. Comparison of the SCORE and REGICOR models for calculating CV risk in CV disease-free individuals at a healthcare center in Barcelona, Spain. Rev Esp Salud Publica 2005, 79:453-464. 10.1590/S1135-57272005000400003, 16465962.
34. Buitrago F, Cañón-Barroso L, Díaz-Herrera N, Cruces-Muro E, Escobar-Fernández M, Serrano-Arias JM. Comparison of the REGICOR and SCORE function charts for classifying CV risk and for selecting patients for hypolipidemic or antihypertensive treatment. Rev Esp Cardiol 2007, 60:139-147. 10.1157/13099460, 17338879.
35. Gil-Guillén V, Orozco-Beltrán D, Maiques-Galán A, Aznar-Vicente J, Navarro J, Cea-Calvo L, Quirce-Andrés F, Redón J, Merino-Sánchez J. Agreement between REGICOR and SCORE scales in identifying high CV risk in the Spanish population. Rev Esp Cardiol 2007, 60:1042-1050. 10.1157/13111236, 17953925.
36. Comín E, Solanas P, Cabezas C, Subirana I, Ramos R, Gené-Badía J, Cordón F, Grau M, Cabré-Vila JJ, Marrugat J. Estimating CV risk in Spain using different algorithms. Rev Esp Cardiol 2007, 60:693-702. 10.1157/13108274, 17663853.
37. Buitrago Ramírez F, Cañón Barroso L, Díaz Herrera N, Cruces Muro E, Bravo Simón B, Pérez Sánchez I. Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the CV risk in an urban population after 10 years of follow-up. Med Clin (Barc) 2006, 127:368-373. 10.1157/13092437, 16987481.
38. del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of CV events in a RA cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737-2745. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#, 11762933.
39. Crowson CS, Gabriel SE. Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 2011, 70:719-721. 10.1136/ard.2010.145482, 21345812.